Business Wire

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

Share

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding. This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase to develop a bactofection platform technology.

“We are excited to advance our vision to create living cures,” said Kristen Albright, PharmD, Chief Executive Officer of Prokarium. “Proceeds of this financing will fund our lead oncology program entering clinical development this year and enable platform expansion for the delivery of novel therapeutic payloads, including RNA, via our proprietary bacteria. With Ginkgo’s partnership and their expertise in strain engineering and optimization we look forward to working towards unlocking a new generation of immuno-oncology therapeutics.”

Prokarium’s lead program has the potential to transform the treatment paradigm in bladder cancer, one of the costliest cancers to treat, in its efforts to become the new standard-of-care in a market that has seen little innovation in over 30 years and to offer advanced therapies an alternative to Bacillus Calmette-Guérin (BCG). Prokarium’s pipeline leverages evolutionary advantages of a proprietary strain of Salmonella and combines them with bespoke synthetic circuits to deliver diverse therapeutic cargo for difficult-to-treat cancers.

“We believe Prokarium is a truly differentiated company,” added Thomas Eldered, Executive Chairman, Flerie Invest. “The new funds and Prokarium’s partnership with Ginkgo Bioworks will accelerate the cutting-edge innovation essential to lead the advancements in the field of synthetic biology and immunotherapy for years to come.”

“Our partnership with Prokarium will utilize Ginkgo’s leading platform capabilities and services to pioneer technological developments that we believe will revolutionize the immuno-oncology field,” added Ena Cratsenburg, Chief Business Officer at Ginkgo Bioworks. “Ginkgo is excited to partner with Prokarium to work to build a versatile Salmonella-based bactofection platform capable of delivering targeted, localized RNA therapeutics.”

In addition to the financing, Prokarium has announced the addition of two scientific advisors, Professor Adrian Hayday, PhD and Sam Chang, MD, MBA. “We are thrilled to welcome Adrian and Sam as advisors as we transition into a clinical-stage company,” concluded Albright. “Adrian brings the deep immunology and immunotherapy expertise, and Sam possesses invaluable clinical experience being involved in numerous bladder cancer clinical trials.” Professor Hayday is the founding Chair of Peter Gorer Department of Immunobiology at King’s College London and is currently Principal Group Leader at the Francis Crick Institute. Sam currently serves as the Chief Surgical Officer at the Vanderbilt Ingram Cancer Center.

About Prokarium
Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy with the vision to create living cures. The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re-engineering evolution into a synthetic biology platform. Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune-driven, long-lasting antitumor effects. Prokarium is based in London, UK. For further information, visit www.prokarium.com.

About Flerie Invest
Flerie Invest is an active long-term global biotech and pharma investor based in Stockholm and London managing a portfolio of over 30 companies in Europe, Israel and the US. The focus is on enabling pioneering organisations operating in the drug development and services space to succeed by providing them with resources and expertise. The portfolio includes a wide range of areas including immuno- oncology, metabolic diseases and biologics development and manufacturing organisations which have the potential to make a significant impact in health and wellbeing. Flerie Invest was founded in 2011 by Thomas Eldered, who also co-founded and built Recipharm to be one of the world’s top five pharmaceutical contract manufacturers. For more information, please visit www.flerie.com.

About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo’s biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

PROKARIUM CONTACT:
Lisa Stone
lisa.stone@prokarium.com

GINKGO BIOWORKS CONTACT:
press@ginkgobioworks.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Laserfiche Recognized as a Strong Performer in Independent Analyst Report on Content Platform Providers24.3.2023 21:38:00 EET | Press release

Laserfiche — the leading SaaS provider of intelligent content management and business process automation — has been named a Strong Performer in The Forrester Wave™: Content Platforms, Q1 2023. Laserfiche was one of 13 vendors evaluated on the strength of its strategy and current offering. Laserfiche earned the highest rating possible in seven criteria: Packaged Applications Search Lifecycle Management Developer Resources App Design/Development Tools Commercial Model Intelligent document extraction According to the report, “Laserfiche has successfully transitioned its 30-plus-year track record in content management into a modern SaaS platform with a well-balanced set of services to deliver a very broad range of vertical and horizontal apps. Its product vision focuses on deeper integration of analytics, structured data sources, and AI/ML, prioritized to align to the needs of its well-defined verticals.” The report also states, “Organizations, including larger enterprises, looking for a S

Q4 Inc. Ranks on The Globe and Mail’s Women Lead Here Benchmark of Executive Gender Diversity24.3.2023 16:15:00 EET | Press release

Q4 Inc. (TSX: QFOR) (“Q4” or “the Company”), a leading capital markets communications platform provider, is proud to announce it has been included on The Globe and Mail’s 2023 Report on Business magazine’s Women Lead Here list. This annual editorial benchmark identifies top-notch Canadian businesses with the highest executive gender diversity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005019/en/ The Executive Women Leaders of Q4 Inc. - Pictured from left to right are Dorothy Arturi, CPO; Lorie Coulombe, SVP, Marketing & Communications; and Donna de Winter, CFO & COO. (Photo: Business Wire) This benchmark was established in 2020 by Report on Business magazine and applies a proprietary research methodology to determine Canadian corporations with the highest degree of gender diversity among executive ranks. The ranking companies have made tangible and organizational progress related to executive gender parity. “I am

ClickHouse, Inc. and Alibaba Cloud Announce a New Partnership24.3.2023 16:00:00 EET | Press release

Today, ClickHouse, Inc., creators of ClickHouse online analytical processing (OLAP) database, and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, announced a partnership that will enable Alibaba Cloud to offer ClickHouse as an enterprise, first-party service on its platform. This partnership is an exclusive agreement between ClickHouse, Inc. and Alibaba Cloud in mainland China to offer a joint first-party enterprise service in APAC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230324005222/en/ Aaron Katz, Founder & CEO, ClickHouse, Inc. (Photo: Business Wire) ClickHouse is the world's fastest and most resource-efficient analytical database, and since it was released as an open-source project in 2016, adoption has grown exponentially – globally. Organisations large and small benefit from the blazing fast speed - with peak processing performance for a single query standing at more than two t

Westlake Epoxy Promoting NEW AZURES™ Systems24.3.2023 13:00:00 EET | Press release

Westlake Corporation (NYSE: WLK) today announced that Westlake Epoxy will launch its new AZURES™ product range at the European Coatings Show 2023, to be held in Nuremberg, Germany, March 28 to 30, 2023. Westlake Epoxy’s Azures™ products are newly developed epoxy resins, modifiers and curing agents that are free of any SVHC- and CMR-labelled substances. As such, they provide better sustainable alternatives to existing technologies used in coatings, civil engineering and adhesives while keeping the same level of performance. “This is definitely another important milestone in Westlake Epoxy’s strategy to contribute to a safer and cleaner world,” said Ann Frederix, Vice President, Westlake Epoxy. Recently, Westlake Epoxy’s European business also confirmed its receipt of the 2022 Platinum Medal from EcoVadis, the world’s largest and most trusted provider of business sustainability ratings, and Westlake Epoxy’s Pernis, Netherlands site has successfully passed the audit for its International

Fischbein International and Votech Expand Manufacturing Footprint in Reusel and Announce New Company Name as Votech, a Duravant Company24.3.2023 11:00:00 EET | Press release

Votech announced today the grand opening of their newly expanded manufacturing facility and company headquarters in Reusel, The Netherlands. This marks the completed integration of two renowned leaders in the packaging industry, Fischbein International and Votech, who came together in 2021 through the acquisition of Votech by Duravant, a global engineered equipment and automation solutions provider to the Food Processing, Packaging and Material Handling sectors. The merger brought together 100+ years of packaging expertise and created a portfolio of technologies that expands the company’s ability to serve customers across a wide array of end markets including agriculture, animal nutrition, fruits and vegetables, ingredients, milk powders and other industrials. Alongside this announcement, the company unveiled their new company logo and brand campaign that reflects the organization’s transformation into a full-line packaging equipment provider. “The names Fischbein, Saxon and Votech, al

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom